Skip to content
Screener

AdaptHealth AHCO Q4 2025 Annual earnings

Reported February 24, 2026 · Before market open

Revenue$846.3MBeat by $14.7M
EPS$0.27Miss by $0.07
Revenue estimate$831.6M
EPS estimate$0.34

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$725.9M
EPS estimate-$0.05

Financials

Q4 2025

Income statement

See full
Revenue$846.3M-1.2%
Gross profit$172.2M-10.4%
Net income-$102.8M-304%
EPS (diluted)-$0.73-315%

Balance sheet

See full
Cash & equivalents$106.1M-3.3%
Total debt$1.9B-10.7%
Total equity$1.5B-3.3%
Total assets$4.3B-3.8%

Cash flow

See full
Operating cash flow$183.2M+21.8%
CapEx$103.9M+34.3%
Free cash flow$79.3M+8.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.35B+5.3%
Enterprise value$3.15B-4.7%
P/S0.4×0.0×

Profitability

See full
Gross margin18.8%-2.1pp
Net margin-2.2%-5.0pp
FCF margin6.8%-0.5pp

Returns & leverage

See full
Return on equity-4.6%-10.6pp
Debt / equity1.3×-0.1×
Current ratio1×-0.3×

Segments

By segment

See full
Sleep Health$372.3M+4.4%
Respiratory Health$178.2M+7.8%
Diabetes Health$158.5M-7.4%
Wellness at Home$137.3M-16.1%

FAQ

When did AdaptHealth report Q4 2025 earnings?
AdaptHealth (AHCO) reported Q4 2025 earnings on February 24, 2026 before market open.
What were AdaptHealth's Q4 2025 revenue and EPS?
AdaptHealth reported revenue of $846.3M and eps of $0.27 for Q4 2025.
Did AdaptHealth beat estimates in Q4 2025?
Revenue beat the consensus estimate of $831.6M by $14.7M. EPS missed the consensus estimate of $0.34 by $0.07.
How did AdaptHealth's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.2% from $856.6M a year earlier and eps declined 30.8% from $0.39.
Where can I find AdaptHealth's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-010872) and the 10-K periodic report (0001628280-26-011213) directly on SEC EDGAR. The filing index links above go to sec.gov.